Table 4.
Postoperative outcome after implementation of a clinical pathway
| Study | Type of surgery | Hospital LoS, days, study group versus control group | Morbidity, %, study group versus control group | Mortality, %, study group versus control group | Readmissions, %, study group versus control group |
|---|---|---|---|---|---|
| van Dam et al. 200816 | HE, EHE, ME, SE, CR, RHE | 6 versus 8 (P < 0.001) | 41 versus 31 (NS) | 0 versus 2 (NS) | 13 versus 10 (NS) |
| Lin et al. 201122 | SE, HE, EHE, CR | 7 versus 11 (P < 0.001) | 46.4 versus 43.3 (NS) | 1.8 versus 1.6 (NS) | 7.1 versus 3.3 (NS) |
| Stoot et al. 200923 | Laparoscopic: ME, SE, LLS | 5 versus 7 (NS) | 15.3 versus 15.3 (NS) | 0 versus 0 (NS) | 0 versus 0 (NS) |
| Functional recovery: 3 versus 5 (P < 0.04) | |||||
| Hendry et al. 201020 | HE, ME, SE, CR | 6 | 17 | 2 | 5 |
| Functional recovery: 4 | |||||
| Koea et al. 200921 | HE, EHE, ME, SE | 4.7 ± 0.9 (intrathecal morphine) 6.8 ± 1.2 (epidural) | 19 | 0 | 4 |
| MacKay & O'Dwyer 200824 | HE, SE | 4 (2–7) | 16.6 | 0 | 0 |
LoS, length of stay; HE, hemi-hepatectomy; EHE; extended hemi-hepatectomy; ME, metastasectomy; SE, segmentectomy; CR, central resection; RHE; repeat hemi-hepatectomy; LLS, left lateral sectionectomy; NS, not significant.